The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Sun., Feb. 25, 8:17 PM

Slide #3. Bio-Path Holdings, Inc. (NASDAQ:BPTH) 1 for 10 Reverse Split

Announced: 2/9/2018
Stock Split: 1 for 10
Record Date: 2/8/2018
Pay Date: 2/9/2018
BPTH Optionable?: No

Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company utilizing a technology that provides systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Co.'s drug delivery and antisense technology is DNAbilize™. Co.'s key drug candidate, prexigebersen targets the protein Grb2 and is also in preclinical studies for solid tumors, including breast cancer and ovarian cancer. Co.'s second drug candidate, Liposomal Bcl2, targets the protein Bcl2, which is responsible for driving cell proliferation in up to 60.0% of all cancers and is in preparation for an Investigational New Drug application.
BPTH Detailed Information Page & Split History »

Company Name: 
Bio-Path Holdings Inc
Website: 
www.biopathholdings.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding BPTH: 
1
Total Market Value Held by ETFs: 
$6339
Total Market Capitalization: 
$19.00M
% of Market Cap. Held by ETFs: 
0.03%

Open the BPTH Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
97th percentile
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2018, All Rights Reserved Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.